Our results (Figure 7) revealed that HT080 decreased anti-apoptotic Bcl-2’s expression and increased pro-apoptotic Bax’s expression compared to the BPH group, thereby decreasing the ratio of Bcl-2/Bax. The gene discussed is BCL2; the disease is benign prostatic hyperplasia.